This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
GE HealthCare (GEHC) reported a 1% growth in existing operation revenues and an increase in profitability in its second quarter of 2024, citing solid performance in its Pharmaceutical Diagnostics segment. On an individual segment basis, GE HealthCare's Imaging segment had flat revenues year over year of $2.22
CHICAGO -- GE HealthCare (GEHC) brought new CT and MRI scanners and a range of AI software applications to McCormick Place for RSNA 2023. GE HealthCare's new Revolution Ascend CT scanner. GE HealthCare's Signa Champion 1.5-tesla MRI GEHC unveiled Signa Champion, a 1.5-tesla, tesla scanner.
Produced by the ACR Committee on Drugs and Contrast Media, the new manual features four updates: An update and addition of Ferumoxytol as a new MRI contrast medium for Chapter 12 – Contrast Media in Children An update for Chapter 13 - Gastrointestinal (GI) Contrast Media in Adults: Indications and Guidelines An evidence-based update with recommendations (..)
Currently, when treating metastatic breast cancer patients, oncologists base clinical decisions on diagnostic tools including biopsy results which only represent the sampled area of the tumor. In the U.S., FES PET, like FDG PET, is now included in the NCCN Guidelines. The NCCN is a not-for-profit alliance of 33 leading U.S.
milla1cf Fri, 06/21/2024 - 20:24 June 21, 2024 — GE HealthCare , a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, and MediView XR Inc., Contact your GE HealthCare or MediView sales representative to learn more.
milla1cf Wed, 10/11/2023 - 13:24 October 11, 2023 — GE HealthCare today announced an exclusive global licensing agreement with SOFIE Biosciences (SOFIE), a Virginia, U.S.-based SOFIE will continue its clinical development and commercialization program with [18F]FAPI-74 in the U.S. Financial terms were not disclosed.
milla1cf Tue, 04/02/2024 - 18:51 April 2, 2024 — Less than three months after signing an agreement to acquire MIM Software Inc. , GE HealthCare Technologies Inc. This includes continuing to grow MIM Software’s offerings for end-to-end standardization across large healthcare system fleets.
He ended his tenure as President and CEO of GE Healthcare Systems in the United States and Canada, where he had responsibility for the core businesses of Imaging, Ultrasound, Life Care Solutions, and Enterprise Digital Solutions. More information: www.usradiology.com Thursday, March 21, 2024 - 10:34
GE HealthCare expects to leverage MIM Software’s imaging analytics and digital workflow capabilities across various care areas to accelerate innovation and differentiate its solutions for the benefit of patients and healthcare systems around the world.
Participants were asked to answer questions pertaining to the healthcare system as a whole based on their personal experiences and observations. In a specialized field like healthcare, resolving that tension is complex and it starts by listening to those who are at the center of care,” said GE HealthCare President and CEO Peter Arduini.
Somebody on the other end of the spectrum might say a theranostics center represents a clinical practice where patients are administered a radiopharmaceutical, with any diagnostic imaging sent out to those who do diagnostic imaging, and then these patients are sent back for clinical care to their medical oncologist for all follow-up," he added.
The clinical trial will use this investigational radiopharmaceutical to help understand if patients have CD8+ T cells in their tumors and will, therefore, be more likely to respond to immune checkpoint inhibitors, the main class of immunotherapies currently approved for use.
milla1cf Fri, 05/05/2023 - 17:31 May 5, 2023 — The American College of Radiology ( ACR ), Breast Cancer Research Foundation (BCRF) and GE HealthCare announce the enrollment of the first patients in the Contrast-Enhanced Mammography Imaging Screening Trial (CMIST). For more information: www.acr.org References: 1] Breastcancer.org.
This collaboration is a significant step forward in our mission to support healthcare providers and patients by providing high-quality medical isotopes. An active DMF enables clinical investigators or pharmaceutical companies to reference the filing in their regulatory submissions.
milla1cf Thu, 11/02/2023 - 13:52 November 2, 2023 — GE HealthCare’s Artificial Intelligence ( AI ) models predict patient response to immunotherapies with 70 to 80 percent accuracy [1] , based on a pan-cancer cohort, according to findings to be presented at the Society for Immunotherapy of Cancer ( SITC ) in San Diego, U.S.,
mtaschetta-millane Wed, 07/24/2024 - 11:17 July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Through this NDA, Telix's objective is to further enhance patient access to PSMA-PET imaging and the clinical benefits of 68Ga imaging to underserved populations across the U.S., Accessed May 2024. [7]
Multimodal, Patient-Centric Registries Accelerate Clinical Trial Enrollment Decisions Once efficiency gains are realized by streamlining noninterpretive, “mundane” imaging curation processes with AI, health systems can begin to build “gold standard” stores of radiology data that are pre-labeled and tagged.
NeuroShield is currently in clinical use in over 220+ sites across the world. A trial of 280 subjects drawn from different parts of the US demonstrated the product's high accuracy across scanners of different magnetic strengths, clinical subgroups, gender, age, slice thickness, and US geographic regions. References: [i] JOSHI, J.
The project is the second funded and supported by NEURii, a global collaboration between the pharmaceutical company Eisai, Gates Ventures, the University of Edinburgh, the medical research charity LifeArc and the national health data science institute Health Data Research UK.
Healthcare has dominated headlines for the better part of the last twenty years. Whether it’s proposals for large-scale reform like the Affordable Care Act or, more recently, the constant news updates surrounding the COVID-19 Pandemic, we are all invested in and impacted by the healthcare news cycle. Promising clinical trials.
It’s observed that in the United States many patients abandon their prescribed medications or disregard their healthcare providers' advice due to high costs. These patterns are gradually impacting the fundamental pillars of the country's value-based healthcare ecosystem, consequently undermining patient outcomes.
The digital pathology solution was cleared for the purpose of primary diagnosis, reported the company, adding that it is cleared (K230839) for clinical use with the Hamamatsu NanoZoomer S360MD Slide scanner in the United States. Up to 70% of clinical decisions depend on pathology 1. Reference: 1. NHS England (2017).
Marco Campione brings more than 25 years of experience from GE HealthCare, where he most recently served as Executive Director and Global Head of Contrast Media, General Manager Pharmaceutical Diagnostics North America and President GE HealthCare Inc., according to a written statement announcing the appointment. “I
Many market segments enjoy unprecedented job growth, but none more than the healthcare sector. The BLS found that the healthcare and social assistance sector will add around 2.1 It’s an excellent time for skilled healthcare workers to look for a job. Multiple factors led to this moment in healthcare recruitment.
CNL will provide the starting material for irradiation and initially manage the production process during the interim scale of radiochemical grade 225Ac supply, while ITM will further process the resulting 225Ac to pharmaceutical grade under Good Manufacturing Process (GMP) specifications. Lutetium-177.
The recommendation was issued by the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA), the primary body in the European Union responsible for regulating pharmaceuticals. The PRAC noted that no clinical diseases or even symptoms have been reported in connection with gadolinium deposition.
The FibroScint program, a collaboration with Capella Imaging, to develop a Tc-99m agent to image fibrin, and collaboration with GE Healthcare to manufacture I-123 capsules are on track for further advancement this year. Ac-225 supply to advance clinical research and ensure adequate availability for commercial radiopharmaceutical products.
The results also follow those of the PICTURE clinical trial published in Investigative Radiology in May, 2023, which found the non-inferior quality of morphologic assessment of lesions of the brain and spine with VUEWAY compared with Gadavist. Bayer HealthCarePharmaceuticals Inc. GE Healthcare. mmol/kg). [i]
26, 2024 — Data scientists and clinical researchers will use brain scans from the entire Scottish population to build a software tool that they hope will help predict a person’s risk of dementia. tim.hodson Mon, 08/26/2024 - 16:49 Aug. million images.
Indian government has taken definitive steps towards inclusive healthcare committing to make India healthier and a model to be emulated by the rest of world. Government schemes like ‘Ayushman Bharat,’ allocates funds towards improving healthcare infrastructure in Tier 2 and 3 cities along with rural areas.
christine.book Thu, 09/07/2023 - 12:19 September 7, 2023 — Paige , a provider of end-to-end digital pathology solutions and clinical AI, has announced a collaboration with Microsoft to build what they refer to as the world’s largest image-based AI models for digital pathology and oncology.
Cardiovascular care has seen remarkable advancements over the decades, from innovative surgical techniques to cutting-edge pharmaceuticals. The question that looms large is how AI can alleviate these burdens, allowing healthcare professionals to spend more time with their patients rather than being bogged down by paperwork and red tape.
Clinical trials for MASH drugs rely on various imaging modalities to provide quantitative and qualitative data regarding liver health, fat content, fibrosis, and inflammation.
of the Qualcomm Institute within the University of California San Diego , finds that question can be difficult to answer since AI products in healthcare do not universally undergo any externally evaluated approval process assessing how it might benefit patient outcomes before coming to market. A new study published in JAMA led by John W.
But grappling with NSF after the fact may be the least troubling issue as healthcare experts scramble to figure out why some patients develop NSF -- and what they can do to prevent NSF from occurring in the first place. Short of a kidney transplant, NSF is difficult to manage. Giles, U.K. Omniscan binds least strongly."
A regular supply chain of affordable medicines and pharmaceuticals is also not in place because of limited indigenous production of drugs and scarce medical research facilities. The operations team would coordinate for any additional information, be it clinical or image related and pass it onto the clinical team.
Experts have long explored computer algorithms meant to improve healthcare, with some having been shown to make valuable clinical predictions. Programs like NYUTron can alert healthcare providers in real time about factors that might lead to readmission and other concerns so they can be swiftly addressed or even averted."
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content